Polymorphisms in genes involved in the triglyceride synthesis pathway and marine omega-3 polyunsaturated fatty acid supplementation modulate plasma triglyceride levels

Journal of Nutrigenetics and Nutrigenomics

Volumn 6, Issue 4-5, 2013, Pages 268-280

  Ouellette, Catherine ^a   Cormier, Hubert ^a   Rudkowska, Iwona ^b   Guénard, Frédéric ^a   Lemieux, Simone ^a   Couture, Patrick ^a,b   Vohl, Marie Claude ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

AGPAT3; AGPAT4; GPAM; Nutrigenomics; Omega 3 polyunsaturated fatty acids; Triacylglycerols

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 3; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 4; APOLIPOPROTEIN B100; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE CHLORIDE; MITOCHONDRIAL ENZYME; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; FISH OIL;

3' UNTRANSLATED REGION; ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXON; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPID METABOLISM; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84907669754     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000357432     Document Type: Article

References (34)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245
2. Statistics Canada: Table 1: Ranking and number of deaths for the 10 leading causes, Canada, 2000 and 2009. 2012
3. Dyerberg J, Banga H, Stoffersena E, Moncadab S, Vaneb J. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117-119
4. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B
5. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-Analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219
6. Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006; 17: 387-393
7. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006; 98: 27i-33i
8. Rudkowska I, Paradis AM, Thifault E, et al. Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation. Genes Nutr 2013; 8: 411-423
9. Callaway CW. CWBC standardization of anthropometric measurements. The Airlie (VA) Consensus Conference. Champaign, Human Kinetics Publishers, 1988
10. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987; 166: 1-8
11. Burstein M, Samaille J. On a rapid determination of the cholesterol bound to the serum alpha-And beta-lipoproteins (in French). Clin Chim Acta 1960; 5: 609
12. Albers JJ, Warnick GR, Wiebe D, et al. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem 1978; 24: 853-856
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, with out use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
14. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
15. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999; 14: 143-149
16. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571
17. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 2006; 15: 2490-2508
18. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292-2333
19. Cormier H, Rudkowska I, Paradis AM, et al. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients 2012; 4: 1026-1041
20. Thifault E, Cormier H, Bouchard-Mercier A, et al. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J Nutrigenet Nutrigenomics 2013; 6: 73-82
21. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008; 88: 618-629
22. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65(suppl 5): 1645S-1654S
23. Madden J, Williams CM, Calder PC, et al. The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. Annu Rev Nutr 2011; 31: 203-234
24. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713
25. Johnson CO, Lemaitre RN, Fahrenbruch CE, et al. Common variation in fatty acid genes and resuscitation from sudden cardiac arrest. Circ Cardiovasc Genet 2012; 5: 422-429
26. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Am J Clin Nutr 1997; 65: 1083-1086
27. Lemaitre RN, Tanaka T, Tang W, et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: a metaanalysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 2011; 7: e1002193
28. Mann NJ, O'Connell SL, Baldwin KM, Singh I, Meyer BJ. Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids 2010; 45: 669-681
29. Wendel AA, Lewin TM, Coleman RA. Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis. Biochim Biophys Acta 2009; 1791: 501-506
30. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 2004; 43: 134-176
31. Hammond LE, Gallagher PA, Wang S, et al. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 2002; 22: 8204-8214
32. Linden D, William-Olsson L, Ahnmark A, et al. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J 2006; 20: 434-443
33. Lu B, Jiang YJ, Zhou Y, Xu FY, Hatch GM, Choy PC. Cloning and characterization of murine 1-Acyl-sn-glycerol-3-phosphate acyltransferases and their regulation by PPARalpha in murine heart. Biochem J 2005; 385: 469-477
34. Lu B, Jiang YJ, Man MQ, Brown B, Elias PM, Feingold KR. Expression and regulation of 1-Acyl-sn-glycerol-3-phosphate acyltransferases in the epidermis. J Lipid Res 2005; 46: 2448-2457